Log in

OTCMKTS:ECTEEcho Therapeutics Stock Price, Forecast & News

+0.00 (+4.00 %)
(As of 05/26/2020 04:00 PM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.01
52-Week Range
Now: $0.01
Volume1,427 shs
Average Volume10,662 shs
Market Capitalization$138,288.80
P/E RatioN/A
Dividend YieldN/A
Echo Therapeutics, Inc. engages in the development of transdermal skin permeation and diagnostic medical devices for wearable-health consumer and diabetes outpatient markets. It is developing continuous glucose monitoring (CGM) system, a needle-free wireless continuous glucose monitoring system in a hospital setting in the European Union. The company has a licensing agreement with Ferndale Pharma Group, Inc. to develop, manufacture, distribute, and market devices for skin preparation prior to the application of topical anesthetics or analgesics prior to a range of needle-based medical procedures in North America, the United Kingdom, South America, Australia, New Zealand, Switzerland, and other portions of the European Community. In addition, it has a license agreement with Handok Pharmaceuticals Co., Ltd. to develop, use, market, import, and sell CGM to medical facilities and individual consumers in South Korea; and a license, development, and commercialization agreement with Medical Technologies Innovation Asia, Ltd to research, develop, manufacture, and use CGM in the People's Republic of China, Hong Kong, Macau, and Taiwan. The company was founded in 1989 and is headquartered in Iselin, New Jersey.
Read More
Echo Therapeutics logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolOTCMKTS:ECTE
Previous SymbolNASDAQ:ECTE



Sales & Book Value

Annual SalesN/A



Market Cap$138,288.80
Next Earnings DateN/A
OptionableNot Optionable

Receive ECTE News and Ratings via Email

Sign-up to receive the latest news and ratings for ECTE and its competitors with MarketBeat's FREE daily newsletter.

Echo Therapeutics (OTCMKTS:ECTE) Frequently Asked Questions

How has Echo Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Echo Therapeutics' stock was trading at $0.0070 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ECTE stock has increased by 48.6% and is now trading at $0.0104. View which stocks have been most impacted by Coronavirus.

How were Echo Therapeutics' earnings last quarter?

Echo Therapeutics Inc (OTCMKTS:ECTE) announced its quarterly earnings data on Friday, August, 12th. The medical device company reported ($0.82) EPS for the quarter. During the same period in the prior year, the company earned ($0.97) EPS. View Echo Therapeutics' earnings history.

Has Echo Therapeutics been receiving favorable news coverage?

News stories about ECTE stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Echo Therapeutics earned a daily sentiment score of -1.9 on InfoTrie's scale. They also assigned media coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutEcho Therapeutics.

Who are some of Echo Therapeutics' key competitors?

What other stocks do shareholders of Echo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Echo Therapeutics investors own include Biocept (BIOC), DexCom (DXCM), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Acer Therapeutics (ACER), Athersys (ATHX), CytRx (CYTR), InterCloud Systems (ICLD), Rexahn Pharmaceuticals (REXN) and Aware (AWRE).

Who are Echo Therapeutics' key executives?

Echo Therapeutics' management team includes the following people:
  • Mr. Alan W. Schoenbart CPA, Chief Exec. Officer, Chief Financial Officer and Director (Age 60)

What is Echo Therapeutics' stock symbol?

Echo Therapeutics trades on the OTCMKTS under the ticker symbol "ECTE."

How do I buy shares of Echo Therapeutics?

Shares of ECTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Echo Therapeutics' stock price today?

One share of ECTE stock can currently be purchased for approximately $0.01.

How big of a company is Echo Therapeutics?

Echo Therapeutics has a market capitalization of $138,288.80. Echo Therapeutics employs 19 workers across the globe.

What is Echo Therapeutics' official website?

The official website for Echo Therapeutics is www.echotx.com.

How can I contact Echo Therapeutics?

Echo Therapeutics' mailing address is 99 WOOD AVENUE SOUTH SUITE 302, ISELIN NJ, 08830. The medical device company can be reached via phone at 732-549-0128 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.